4.3 Article

Suppressive action of acetate on interleukin-8 production via tubulin-α acetylation

期刊

IMMUNOLOGY AND CELL BIOLOGY
卷 92, 期 7, 页码 624-630

出版社

WILEY
DOI: 10.1038/icb.2014.31

关键词

-

资金

  1. Japan Society for the Promotion of Science
  2. Grants-in-Aid for Scientific Research [24590317] Funding Source: KAKEN

向作者/读者索取更多资源

Acetate is the major short-chain fatty acid produced by commensal bacteria in the gut and is known as a nutrient source for epithelial cells of the mucosa. Acetate also suppresses interleukin (IL)-2 production in T cells by inhibiting nuclear factor of activated T cells (NFAT) nuclear translocation via tubulin-alpha acetylation. Using acetylation of tubulin-alpha as a biomarker, we have examined the influence of acetate in the large intestine. Because of high concentrations of acetate in fecal material, tubulin-alpha acetylation is dominant in the proximal large intestine relative to other sections of the large intestine and is induced in epithelial cells of the colonic mucosa. Flagellin stimulation induces IL-8 production in epithelial cells and acetate suppresses this IL-8 production via tubulin-alpha acetylation. Flagellin stimulation activates nuclear factor-kappa B, CREB and AP-1, but not NFAT. Of these transcription factors, acetate specifically inhibits AP-1 activation. Acetate impairs flagellin-induced activation of the Rap1-MEK-ERK-Elk-1 pathway with acetylation of tubulin-alpha that is bound to Rap1, resulting in reduced expression of c-Fos, a subunit of AP-1. These findings reveal a novel action of acetate via tubulin-alpha acetylation in epithelial cells of the colonic mucosa.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Recent progress of chemotherapy and biomarkers for gastroesophageal cancer

Osamu Maeda, Yuichi Ando

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)

Article Gastroenterology & Hepatology

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Kazuyuki Mizuno, Takanori Ito, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Hiroki Kawashima, Yosuke Inukai, Hidenori Toyoda, Kenji Yokota, Tetsunari Hase, Osamu Maeda, Hitoshi Kiyoi, Masato Nagino, Hideharu Hibi, Yasuhiro Kodera, Yasushi Fujimoto, Michihiko Sone, Momokazu Gotoh, Yuichi Ando, Masashi Akiyama, Yoshinori Hasegawa, Mitsuhiro Fujishiro

JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Takanori Ito, Masatoshi Ishigami, Takafumi Yamamoto, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hiroki Kawashima, Satoshi Yasuda, Hidenori Toyoda, Kenji Yokota, Tetsunari Hase, Naoki Nishio, Osamu Maeda, Masashi Kato, Naozumi Hashimoto, Hideharu Hibi, Yasuhiro Kodera, Michihiko Sone, Yuichi Ando, Masashi Akiyama, Yoshie Shimoyama, Mitsuhiro Fujishiro

Summary: The occurrence pattern and therapeutic response to corticosteroids in immune-related liver injury differ according to the injury type, with corticosteroids effective for the hepatocellular pattern but not for refractory non-hepatocellular patterns, indicating the need for additional strategies in such cases.

HEPATOLOGY INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival

Kentaro Yamada, Tsunaki Sawada, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Eri Ishikawa, Tadashi Iida, Yasuyuki Mizutani, Naomi Kakushima, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Satoshi Furune, Tetsunari Hase, Kenji Yokota, Osamu Maeda, Naozumi Hashimoto, Masashi Akiyama, Yuichi Ando, Mitsuhiro Fujishiro

Summary: This study evaluated the clinical characteristics of GI-irAEs and their impact on survival in patients treated with ICIs. It found that patients receiving anti-CTLA-4 antibodies develop GI-irAEs more frequently and with higher severity, but continuing ICI treatment in patients with MM with GI-irAEs results in better overall survival.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury

Takafumi Yamamoto, Hikaru Morooka, Takanori Ito, Masatoshi Ishigami, Kazuyuki Mizuno, Shinya Yokoyama, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Kenji Yokota, Tetsunari Hase, Osamu Maeda, Naozumi Hashimoto, Yuichi Ando, Masashi Akiyama, Hiroki Kawashima

Summary: The cumulative incidence of immune-related liver injury (liver-irAE) was investigated using a clustering analysis based on inflammatory markers. The study found that the combined assessment of multiple markers and body temperature may help stratify high-risk groups for developing liver-irAE.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Letter Oncology

Selection of chemotherapy for older patients with pancreatic cancer based on geriatric assessment

Osamu Maeda, Ayumu Matsuoka, Madoka Yanagawa, Yukie Muroyama, Kazuhisa Watanabe, Yao Liang, Takuya Ishikawa, Eizaburo Ohno, Hiroki Kawashima, Hiroyuki Umegaki, Masafumi Kuzuya, Yuichi Ando

JOURNAL OF GERIATRIC ONCOLOGY (2022)

Article Oncology

Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer

Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Dai Shimizu, Shizuki Sugita, Tohru Okada, Junji Ito, Mariko Kawamura, Shunichi Ishihara, Masahiro Nakatochi, Masahiko Ando, Yasuhiro Kodera, Yuichi Ando

Summary: The feasibility of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer was assessed in this study. The study conducted at Nagoya University Hospital reviewed the outcomes of patients who received global standard chemoradiotherapy followed by surgery compared to those who received lower drug doses. The results showed that the global standard regimen was associated with more severe adverse events but no significant difference in resection rate or complications.

MOLECULAR AND CLINICAL ONCOLOGY (2023)

Article Medicine, Research & Experimental

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Mitsuro Kanda, Dai Shimizu, Kazushi Miyata, Osamu Maeda, Chie Tanaka, Yoshikuni Inokawa, Norofumi Hattori, Masamichi Hayashi, Masahiko Ando, Yachiyo Kuwatsuka, Kenta Murotani, Goro Nakayama, Masahiko Koike, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera

Summary: This study aims to assess the safety and efficacy of neoadjuvant docetaxel, oxaliplatin, and S-1 combination therapy for patients with clinical stage III esophageal squamous cell carcinoma.

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2021)

Review Medicine, Research & Experimental

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review

Osamu Maeda, Fumiharu Ohka, Satoshi Maesawa, Ayumu Matsuoka, Tomoya Shimokata, Ayako Mitsuma, Hiroshi Urakawa, Shota Nakamura, Yoshic Shimoyamas, Masato S. Nakaguro, Toshihiko Wakabayashi, Yuichi Ando

NAGOYA JOURNAL OF MEDICAL SCIENCE (2020)

Article Medicine, Research & Experimental

Chemotherapy for biliary tract cancer: real-world experience in a single institute

Osamu Maeda, Tomoki Ebata, Tomoya Shimokata, Ayumu Matsuoka, Megumi Inada-Inoue, Sachi Morita, Yuko Takano, Hiroshi Urakawa, Yuki Miyai, Mihoko Sugishita, Ayako Mitsuma, Masahiko Ando, Takashi Mizuno, Masato Nagino, Yuichi Ando

NAGOYA JOURNAL OF MEDICAL SCIENCE (2020)

Article Medicine, Research & Experimental

Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5′-Deoxy-5-fluorocytidine, and Creatinine Clearance

Takahiro Inaishi, Ken-Ichi Fujita, Natsumi Matsumoto, Tomoya Shimokata, Osamu Maeda, Toyone Kikumori, Norifumi Hattori, Goro Nakayama, Yuichi Ando

IN VIVO (2020)

Review Medicine, Research & Experimental

Nonexposed wall-inversion surgery as a novel local resection method for neoplasms in the gastrointestinal tract

Mitsuhiro Fujishiro, Kazuhiro Furukawa, Takeshi Yamamura, Masanao Nakamura, Takashi Honda, Osamu Maeda, Masatoshi Ishigami, Hiroki Kawashima

NAGOYA JOURNAL OF MEDICAL SCIENCE (2020)

Article Oncology

Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapy

Osamu Maeda, Ayumu Matsuoka, Kazuhiro Furukawa, Ryoji Miyahara, Yoshiki Hirooka, Yuichi Ando

MOLECULAR AND CLINICAL ONCOLOGY (2019)

Article Medicine, Research & Experimental

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study

Nao Takano, Suguru Yamada, Akihiro Hirakawa, Yukihiro Yokoyama, Hiroki Kawashima, Osamu Maeda, Tohru Okada, Eizaburo Ohno, Junpei Yamaguchi, Takuya Ishikawa, Fuminori Sonohara, Masaya Suenaga, Hideki Takami, Masamichi Hayashi, Yukiko Niwa, Yoshiki Hirooka, Yoshiyuki Ito, Shinji Naganawa, Yuichi Ando, Masato Nagino, Hidemi Goto, Tsutomu Fuji, Yasuhiro Kodera

NAGOYA JOURNAL OF MEDICAL SCIENCE (2019)

Meeting Abstract Gastroenterology & Hepatology

Modified Docetaxel plus Cisplatin plus Capecitabine (DCX) for Gastric Cancer

Osamu Maeda, Yuichi Ando, Ayumu Matsuoka, Kazuhiro Furukawa, Kohei Funasaka, Ryoji Miyahara, Yoshiki Hirooka, Hidemi Goto

DIGESTION (2019)

暂无数据